[Federal Register Volume 68, Number 47 (Tuesday, March 11, 2003)]
[Notices]
[Page 11567]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-5641]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 03F-0048]


BASF Corp.; Filing of Food Additive Petition (Animal Use)--
Conjugated Linoleic Acid

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing that BASF 
Corp. has filed a petition proposing that the food additive regulations 
be amended to provide for the safe use of conjugated linoleic acid in 
animal feed.

DATES: Submit written or electronic comments by May 26, 2003.

ADDRESSES: Submit written comments to the Dockets Management Branch 
(HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, 
Rockville, MD 20852. Submit electronic comments to http://www.fda.gov/dockets/ecomments.

FOR FURTHER INFORMATION CONTACT: Sharon A. Benz, Center for Veterinary 
Medicine (HFV-228), Food and Drug Administration, 7500 Standish Pl., 
Rockville, MD 20855, 301-827-6656, e-mail: [email protected].

SUPPLEMENTARY INFORMATION: Under the Federal Food, Drug, and Cosmetic 
Act (sec. 409(b)(5) (21 U.S.C. 348(b)(5))), notice is given that a food 
additive petition (FAP 2250) has been filed by BASF Corp., 3000 
Continental Dr.-North, Mount Olive, NJ 07828-1234. The petition 
proposes to amend the food additive regulations in part 573 Food 
Additives Permitted in Feed and Drinking Water of Animals (21 CFR part 
573) to provide for the safe use of conjugated linoleic acid (CLA) as a 
source of fatty acids in swine diets at levels not to exceed 1 percent 
in complete feed.
    The potential environmental impact of this action is being 
reviewed. To encourage public participation consistent with regulations 
issued under the National Environmental Policy Act (40 CFR 1501.4(b)), 
the agency is placing the environmental assessment submitted with the 
petition that is the subject of this notice on public display at the 
Dockets Management Branch (see ADDRESSES) for public review and 
comment.
    Interested persons may submit to the Dockets Management Branch (see 
ADDRESSES) written or electronic comments regarding this document. 
Submit a single copy of electronic comments to http://www.fda.gov/dockets/ecomments or two hard copies of any written comments, except 
that individuals may submit one hard copy. Comments are to be 
identified with the docket number found in brackets in the heading of 
this document. Received comments may be seen in the Dockets Management 
Branch between 9 a.m. and 4 p.m., Monday through Friday. FDA will also 
place on public display any amendments to, or comments on, the 
petitioner's environmental information without further announcement in 
the Federal Register. If, based on its review, FDA finds that an 
environmental impact statement is not required and this petition 
results in a regulation, the notice of availability of the agency's 
finding and the evidence supporting that finding will be published with 
the regulation in the Federal Register in accordance with 21 CFR 
25.40(c).

    Dated: February 27, 2003.
Stephen F. Sundlof,
Director, Center for Veterinary Medicine.
[FR Doc. 03-5641 Filed 3-10-03; 8:45 am]
BILLING CODE 4160-01-S